Renascience Inc. 4889.T Stock
Renascience Inc. Price Chart
Renascience Inc. 4889.T Financial and Trading Overview
| Renascience Inc. stock price | 343 JPY |
| Previous Close | 471 JPY |
| Open | 473 JPY |
| Bid | 480 JPY x N/A |
| Ask | 483 JPY x N/A |
| Day's Range | 467 - 489 JPY |
| 52 Week Range | 282 - 620 JPY |
| Volume | 462.5K JPY |
| Avg. Volume | 322.42K JPY |
| Market Cap | 6.11B JPY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -26.08 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4889.T Valuation Measures
| Enterprise Value | 4.08B JPY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 61.143276 |
| Price/Book (mrq) | 3.278465 |
| Enterprise Value/Revenue | 40.842 |
| Enterprise Value/EBITDA | -12.265 |
Trading Information
Renascience Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 41.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 620 JPY |
| 52 Week Low | 282 JPY |
| 50-Day Moving Average | 479.66 JPY |
| 200-Day Moving Average | 389.72 JPY |
4889.T Share Statistics
| Avg. Volume (3 month) | 322.42K JPY |
| Avg. Daily Volume (10-Days) | 995.7K JPY |
| Shares Outstanding | 12.71M |
| Float | 4.3M |
| Short Ratio | N/A |
| % Held by Insiders | 69.85% |
| % Held by Institutions | 14.03% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -334.00000000000000000000000000000000% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -8.85% |
| Return on Equity (ttm) | -16.48% |
Income Statement
| Revenue (ttm) | 100M JPY |
| Revenue Per Share (ttm) | 7.87 JPY |
| Quarterly Revenue Growth (yoy) | -4.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -333000000 JPY |
| Net Income Avi to Common (ttm) | -335000000 JPY |
| Diluted EPS (ttm) | -26.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.21B JPY |
| Total Cash Per Share (mrq) | 174.01 JPY |
| Total Debt (mrq) | 309M JPY |
| Total Debt/Equity (mrq) | 16.57 JPY |
| Current Ratio (mrq) | 22.67 |
| Book Value Per Share (mrq) | 146.715 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -284000000 JPY |
| Levered Free Cash Flow (ttm) | -159750000 JPY |
Profile of Renascience Inc.
| Country | Japan |
| State | N/A |
| City | Tokyo |
| Address | 2-3-6 |
| ZIP | 103-0023 |
| Phone | 81 3 6262 0873 |
| Website | https://www.renascience.co.jp |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Renascience Inc. engages in the development and commercialization of pharmaceuticals and medical devices. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets; and RS8001, a water-soluble vitamin for use in the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. It is also developing RS9001, a disposable ultrafine endoscope; artificial intelligence based medical solutions; and diagnostic solutions. The company was incorporated in 2000 and is headquartered in Chuo, Japan.
Q&A For Renascience Inc. Stock
What is a current 4889.T stock price?
Renascience Inc. 4889.T stock price today per share is 343 JPY.
How to purchase Renascience Inc. stock?
You can buy 4889.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Renascience Inc.?
The stock symbol or ticker of Renascience Inc. is 4889.T.
Which industry does the Renascience Inc. company belong to?
The Renascience Inc. industry is Medical Devices.
How many shares does Renascience Inc. have in circulation?
The max supply of Renascience Inc. shares is 12.71M.
What is Renascience Inc. Price to Earnings Ratio (PE Ratio)?
Renascience Inc. PE Ratio is now.
What was Renascience Inc. earnings per share over the trailing 12 months (TTM)?
Renascience Inc. EPS is -26.08 JPY over the trailing 12 months.
Which sector does the Renascience Inc. company belong to?
The Renascience Inc. sector is Healthcare.